{"title":"Study of hemolysis interference with a peak rate nephelometric assay of lipoprotein(a)","authors":"Fabrice Lefèvre, Philippe Gillery","doi":"10.1002/(SICI)1098-2728(2000)12:1<23::AID-LRA4>3.0.CO;2-8","DOIUrl":null,"url":null,"abstract":"<p>Lipoprotein(a) [Lp(a)] is considered an independent risk factor in atherosclerosis and thrombosis. Its measurement in clinical laboratories necessitates the use of reliable methods and a strict control of preanalytical conditions. We studied here the potential interference of hemolysis on a peak rate nephelometric method. Serum samples were spiked with up to 500 μmol/L hemoglobin (Hb), and Lp(a) was measured with a Beckman Array 360 analyzer. Hb supplementation induced a significant decrease of Lp(a) values: −15% and −25% (p < 0.01) for Hb concentrations 200 and 500 μmol/L, respectively. Similar results were obtained when Hb addition was done before and after the manual step of sample predilution (1/5, v/v) in PEG-containing buffer. No significant difference of Hb interference was noticed according to apo(a) phenotypes. Our results indicate that hemolysis may significantly alter Lp(a) values obtained with this method, probably because of the low-dilution rate of samples. Even if this interference is of limited extent, it should be taken into account when interpretating results close to decisional values used for risk assessment. © 2000 John Wiley & Sons, Inc. Lab Robotics and Automation 12:23–26, 2000</p>","PeriodicalId":100863,"journal":{"name":"Laboratory Robotics and Automation","volume":"12 1","pages":"23-26"},"PeriodicalIF":0.0000,"publicationDate":"2000-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/(SICI)1098-2728(2000)12:1<23::AID-LRA4>3.0.CO;2-8","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Laboratory Robotics and Automation","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/%28SICI%291098-2728%282000%2912%3A1%3C23%3A%3AAID-LRA4%3E3.0.CO%3B2-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Lipoprotein(a) [Lp(a)] is considered an independent risk factor in atherosclerosis and thrombosis. Its measurement in clinical laboratories necessitates the use of reliable methods and a strict control of preanalytical conditions. We studied here the potential interference of hemolysis on a peak rate nephelometric method. Serum samples were spiked with up to 500 μmol/L hemoglobin (Hb), and Lp(a) was measured with a Beckman Array 360 analyzer. Hb supplementation induced a significant decrease of Lp(a) values: −15% and −25% (p < 0.01) for Hb concentrations 200 and 500 μmol/L, respectively. Similar results were obtained when Hb addition was done before and after the manual step of sample predilution (1/5, v/v) in PEG-containing buffer. No significant difference of Hb interference was noticed according to apo(a) phenotypes. Our results indicate that hemolysis may significantly alter Lp(a) values obtained with this method, probably because of the low-dilution rate of samples. Even if this interference is of limited extent, it should be taken into account when interpretating results close to decisional values used for risk assessment. © 2000 John Wiley & Sons, Inc. Lab Robotics and Automation 12:23–26, 2000
峰值速率浊度法测定脂蛋白溶血干扰的研究(a)
脂蛋白(a) [Lp(a)]被认为是动脉粥样硬化和血栓形成的独立危险因素。在临床实验室中,它的测量需要使用可靠的方法和严格控制分析前条件。本文研究了溶血对峰速率浊度法的潜在干扰。血清样品加入高达500 μmol/L的血红蛋白(Hb),用Beckman Array 360分析仪测定Lp(a)。补充Hb导致Lp(a)值显著降低:- 15%和- 25% (p <Hb浓度分别为200和500 μmol/L, p < 0.01)。在含peg缓冲液中样品预稀释(1/5,v/v)的手动步骤之前和之后分别添加Hb,得到类似的结果。根据载脂蛋白(a)表型,Hb干扰无显著差异。我们的结果表明,溶血可能会显著改变用这种方法获得的Lp(a)值,可能是因为样品的稀释率低。即使这种干扰程度有限,在解释接近用于风险评估的决策值的结果时也应考虑到这种干扰。©2000 John Wiley &儿子,Inc。实验室机器人与自动化,2000
本文章由计算机程序翻译,如有差异,请以英文原文为准。